Background: Peripartum cardiomyopathy (PPCM) is characterized by left ventricular systolic dysfunction and heart failure. However, its pathogenesis is not clear. Our preliminary study revealed that autoantibodies against b 1 -adrenergic receptors (b 1 R-AABs) and M 2 -muscarinic receptors (M 2 R-AABs) participated in heart failure regardless of primary heart disease. Whether b 1 R-AABs and M 2 R-AABs participate in the pathogenesis of PPCM is still unknown.
Introduction
Peripartum cardiomyopathy (PPCM) is a serious disease with unknown etiology, which occurs between the last month of pregnancy and 5-month puerperium with significant morbidity and mortality. The diagnostic criteria include: (1) The disease occurs between the last month of pregnancy and 5-month puerperium; (2) There has no definite reason for heart failure; (3) LVEF ,45%, LVFS ,30%. The reported incidence fluctuates among geographic regions, but it is higher in Africa. It has been estimated to be 1:3000-4000 in USA, 1:400 in Haiti, and 1:1000 in South Africa [1] . Although the mechanism of PPCM is still unknown, increasing evidences suggest that autoimmunity may play an important role in the development of PPCM [2] .
The role of autoimmunity in cardiovascular diseases has become one of the focal points in the field of cardiomyopathy and heart failure. The b 1 -adrenergic and M 2 -muscarinic receptors belong to the family of cardiac G-protein-coupled receptors. Circulating autoantibodies against the second extracellular loop of b 1 -adrenergic receptors and M 2 -muscarinic receptors have been detected in a number of cardiovascular diseases characterized by heart failure including idiopathic dilated cardiomyopathy (IDCM) [3] and chronic Chagas' heart disease (ChHD) [4] . PPCM patients have been confirmed to be positive for b 1 R-AABs [5] . Our previous studies have also demonstrated that b 1 R-AABs and M 2 RAABs are highly prevalent and participated in the pathogenesis of dilated cardiomyopathy. In addition, the density of b 1 R-AABs and M 2 R-AABs is significantly higher in patients with heart failure regardless of the primary heart disease [6] . The purpose of this study is to determine whether PPCM is correlated with the serum levels of b 1 R-AABs and M 2 R-AABs.
Results

Study Characteristics
The characteristics of the study population at the first presence in cardiac clinic (baseline) are shown in Table 1 . All these patients were diagnosed as PPCM for the first time. Totally 13 of 37 patients were primiparous, and 21 of 37 patients with symptoms in the postpartum period: all within three months after delivery. At baseline, one patient was in NYHA FC II, 16 patients in FC III and 20 patients in FC IV. The clinical profiles of the study population including patients with PPCM and normal pregnant group were summarized in Table 2 . Compared with normal pregnant women, PPCM patients had a higher heart rate and blood pressure (P,0.05). Left ventricular dimension was significantly enlarged and left ventricular ejection fraction coincided with left ventricular fractional shortening was significantly decreased (P,0.001).
Autoantibody Screening
The positive sera for b 1 R-AABs were observed in 59.5% (22/ 37) of PPCM patients, while 19.4% (7/36) (P,0.001) in normal pregnant women. The positive sera for M 2 R-AABs were 45.9% (17/37) in PPCM patients, while 16.67% (6/36) (P,0.001) in normal pregnant women. Moreover, in positive cases, autoantibody titer (geometric mean) was higher in patients with PPCM when compared with normal pregnant women both for b 1 R-AABs and M 2 R-AABs. The geometric mean titers for b 1 R-AABs and M 2 R-AABs were 1:129 and 1:143, while they were 1:80 (P = 0.003) and 1:53 (P,0.001) in normal pregnant women. Totally 17 of 37 (46%) PPCM patients were positive for both b 1 RAABs and M 2 R-AABs. Among other 19 patients, 15 (40%) patients were negative for b 1 R-AABs and M 2 R-AABs, and 5 (14%) patients were positive for b 1 R-AABs.
Follow-up Examination
One patient (3%) died during the study period. The death was due to the progression of heart failure. Since the death was due to the progression of heart failure, patients who died were classified in FC IV at the latest follow-up examination. All patients received standard therapy for heart failure, which included daily 0.125 mg of digitalis, furosemide [median daily dose 40 mg (20- 
LV Function, Dimension and Heart Rate
Patients who completed 12 months of standard therapy showed a significant reduction in heart rate, LV dimension, and significant improvement in echocardiographic LVEF and LVFS (P#0.001) and NYHA FC (P,0.001). Normalization of LVEF ($50%) was observed in 31 (86.1%) patients. Clinical data and NYHA FC were compared at the first presence in the cardiac clinic at baseline and after 12 months of standard therapy as described in Table 3 .
Dynamic Variation of Autoantibody
After 12 months treatment, the positive rate for b 1 R-AABs declined from 59.5% to 22.2% (P,0.001), as well as M 2 R-AABs declined from 45.9% to 19.4% (P,0.001). The geometric means of autoantibodies were also decreased significantly (P,0.001). The geometric mean titers for b 1 R-AABs and M 2 R-AABs were declined from 1:129 to 1:71 and 1:143 to 1:50, respectively ( Figure 1 ). 
Comparison of Echocardiographic Data from Patients with Different Positive Autoantibodies
Determinant of Serum Antibody Levels
The levels of serum b 1 R-AABs and M 2 R-AABs (both frequency and titer of autoantibody) were positively correlated with left ventricular dimension, NT-proBNP and NYHA FC (Spearman coefficient differs from 0.378 to 0.590, all P,0.05). Besides the levels of serum b 1 R-AABs and M 2 R-AABs (both frequency and titer of autoantibody) were negatively correlated with LVEF and LVSF (Spearman coefficient differs from 20.390 to 20.570, all P,0.05). A significant correlation was observed between b 1 RAABs and M 2 R-AABs (rs = 0.886, P,0.001). The results were described in Tables 4 and 5 .
Correlation of b 1 R-AABs and M 2 R-AABs and the Onset of Peripartum Cardiomyopathy
Univariate analysis showed that several factors increased the risk for the onset of PPCM, including autoantibodies against cardiovascular receptors, advanced maternal age, multiple pregnancies, pregnancy-induced hypertension, and poor socioeconomic status. Multiple logistic analysis showed that the level of autoantibodies against cardiovascular receptors and pregnancy-induced hypertension were an independent predictor of the PPCM attack (autoantibodies against cardiovascular receptors: OR = 18.786, 95% confidence interval 1.926-183.262, P = 0.012; pregnancyinduced hypertension: OR = 17.305, 95% confidence interval 1.061-282.299, P = 0.045). The result was shown in Table 6 .
Discussion
Major Findings
In this study, synthetic peptides corresponding to the sequences of the second extracellular loop of human b 1 receptor (amino acid sequence number: 197-222) and M 2 receptor (amino acid sequence number: 169-193) were used. We detected the autoantibodies against b 1 and M 2 receptors in patients' sera with ELISA and demonstrated that the frequency and titer of serum During the past few years, autoimmune mechanisms in heart disease have gained extensive attentions. Autoimmunity has been observed in several cardiovascular diseases such as dilated cardiomyopathy (DCM) and heart failure, rheumatic fever, myocarditis, atherosclerosis, and others [7] [8] . Belonging to the family of G protein-coupled receptors, b 1 R and M 2 R are the major adrenergic and muscarinic receptors present in myocardial tissue, respectively [9] [10] . b 1 R-AABs and M 2 R-AABs were first detected in the idiopathic dilated cardiomyopathy (IDCM) [11] [12] . IDCM is characterized by systolic dysfunction and chamber dilatation of the left heart or both left and right ventricles as same as PPCM. Further studies have demonstrated that autoimmune mechanisms seem to play a major role in the pathogenesis of IDCM. Monthly immunization of rabbits for 1 year using synthetic peptides corresponding to the sequence of the second extracellular loop of either the human b 1 R or M 2 R could induce cardiac morphological changes including significantly enlarged ventricles and thinner walls, resembling the changes of IDCM in humans [13] . Others have attempted to conduct mouse immunization by using plasmid DNA encoding entire human b 1 AR or M 2 R proteins, which can lead to contractile dysfunction and cardiac remodeling [14] .
Our preliminary study revealed that b 1 R-AABs and M 2 R-AABs not only existed in IDCM patients, but also in heart failure caused by different cardiac diseases. Moreover, the serum level of autoantibody has no significant difference among different heart diseases, which suggested that the generation of b 1 R-AABs and M 2 R-AABs had no relationship with primary heart disease, but was correlated with the damage of cardiac function.
Autoimmune Mechanisms in PPCM
PPCM is characterized as systolic dysfunction and heart failure as well as IDCM. Its pathogenesis was still unclear. The autoimmune mechanism was believed to participate in the pathogenesis of PPCM. High titers of auto-antibodies against selected cardiac tissue proteins have been found in the majority of women with PPCM [15] . Warraich et al. investigated the role of humoral immunity and showed that class G and all subclass immunoglobulins against cardiac myosin heavy chain were raised in PPCM [16] . Recent studies further confirmed that b 1 R-AABs existed in the serum of PPCM patients, and was correlated with plasma NT-proBNP [5] .
Autoantibodies and PPCM
Previous studies revealed that b 1 R-AABs and M 2 R-AABs might lead to cardiac remodeling in cardiomyopathy. In the present study, significantly higher levels of b 1 R-AABs and M 2 R-AABs in the serum of PPCM than normal pregnant women were observed. For PPCM patients, the enlarged left ventricular chamber may return to normal level, which seems to improve better than IDCM. In our study, the titer of autoantibodies revealed a decline, which is coincided with the decrease of left ventricular and the improvement of heart function after treatments. Therefore, b 1 R- AABs and M 2 R-AABs may participate in the pathological change of cardiomyocytes. What's more, these two autoantibodies were the independent risk factors for the attack of PPCM and may influence the prognosis of PPCM patients. All of these investigations suggested that b 1 R-AABs and M 2 R-AABs might participate in the pathogenesis of PPCM.
It's interesting to notice that, a hypothesis currently being widely entertained is that PPCM may be a vascular disease [17] . Antiangiogenic factor (sFlt1), which is markedly elevated in preeclampsia, is involved in the pathogenesis of PPCM. Another novel pilot study has demonstrated for the first time that the presence of autoantibodies against b 1 is increased in patients with preeclampsia [18] , which is the risk factor for PPCM. Whether the autoantibodies against cardiovascular receptors are associated with the elevation of antiangiogenic factors, thus leading to that further studies of PPCM still are needed. Table 4 . Correlation between serum anti-b 1 R-AAB levels and other parameters.
Frequency of autoantibody
Titer of autoantibody 
Study Limitations
PPCM is a diagnosis by exclusion. As the objects of this study are pregnant women, the coronary angiography, and right and left catheterization are not allowed for application to exclude other kinds of cardiac diseases. Because the morbidity of PPCM is not very high in China, especially in Beijing, the case number is insufficient. As all these patients enrolled in our study were Chinese Han and body mass index (BMI) was not mentioned in this article, the assessment of autoantibodies as an independent risk factor for PPCM were incomplete, which could result in the continuous improvement in the future. What's more, the predictive value of autoantibodies against cardiovascular receptors for the prognosis of PPCM needs further studies.
Conclusion
This study has demonstrated that the presence of b 1 R-AABs and M 2 R-AABs were prevalent in a cohort of PPCM patients. The positive rates and the serum titers of b 1 R-AABs and M 2 R-AABs were positively correlated with left ventricular dimension, and negatively correlated with the cardiac contraction function of PPCM patients. The autoantibodies of cardiovascular receptors were independent risk factors for the onset of PPCM.
We propose that autoantibodies against cardiovascular receptors may be involved in the pathogenesis of PPCM. Further studies are needed to confirm these findings and dissect the underlying mechanisms for this novel observation.
Materials and Methods
Study Design and Patient Enrollment
The protocol as well as the consent form was approved by the Ethics Committee of Capital Medical University Beijing ChaoYang Hospital and the study protocol complied with the Declaration of Helsinki. All participants provided written informed consent prior to admission into the study.
Since 1998, 37 Chinese Hanpatients with newly diagnosed PPCM were enrolled in Beijing Chao-Yang Hospital. The enrolled patients should meet following inclusion criteria: (1) age $16 or #40 years old, (2) New York Heart Association functional classes (NYHA FCs) II-IV, (3) symptoms of congestive heart failure developed in the last month of pregnancy or during the first 5 months post-partum, (4) no other identifiable causes for heart failure, (5) left ventricular ejection fraction (LVEF) ,45%, left ventricular fractional shortening ,30% by transthoracic echocardiography, (6) sinus rhythm and (7) eligible patients with high quality echocardiographic images. Exclusion criteria: (1) significant organic valvular heart disease, (2) systolic blood pressure (SBP) .160 mmHg and/or diastolic blood pressure .100 mmHg, (3) clinical conditions other than cardiomyopathy with increased autoantibody by screening the serum for rheumatoid arthritis and HIV and the evidence of sepsis, (4) severe anaemia (haemoglobin concentration ,9 g/dL), (5) metabolic disorders affecting lipoprotein metabolism such as thyroid disease and (6) Clinical data are not complete. Clinical assessment, echocardiography and blood analysis were conducted at baseline and after 12 months of standard therapy. All patients received standard therapy for PPCM (b-blocker, angiotensin-converting Table 5 . Correlation between serum anti-M 2 R-AAB levels and other parameters.
Frequency of autoantibody
Autoantibody Detection
The autoantibodies against b 1 -adrenergic and M 2 -muscarinic receptors were measured in patient sera through an enzyme-linked immunosorbent assay (ELISA) using a synthetic peptide corresponding to the sequence of the second extracellular loop of human b 1 and M 2 receptor (amino acid sequence number, A total of 50 mL of patient serum with gradient dilutions from 1:20 to 1:160 was added to saturated microtiter plates and incubated for 1 h at 37uC. After the wells were washed with PBS-T for 3 times, an affinity-purified biotinylated rabbit anti-human IgG (H+L) antibody (Jackson Laboratories, PA, USA) (1:500 dilution in PMT) was added and allowed to react for 1 h. After washing the wells for 3 times with PBS-T, the bound biotinylated antibody was detected by incubating the plates for 1 h with streptavidin-peroxidase (2 ml/ L) (Jackson Laboratories, PA, USA) solution in PMT, which was followed by washing for 3 times with PBS and the addition of substrate for peroxidase 2.5 mmol/L H 2 O 2 -2 mmol/L ABTS (Sigma, St. Louis, MO, USA). Optical density (OD) was recorded after 30 min at 405 nm in a micro plate reader (Molecular Devices Corp, Menlo Park, CA, USA). Positive rate was defined as positive/negative [P/N = (sample OD-blank OD)/blank OD)] $2.1 [19] [20] [21] . The titer of autoantibody is the highest degree of the sample with P/N$2.1 when diluted from 1:20 to 1:160.
Echocardiographic Studies
All studies were performed and interpreted by the same operator who was blinded to the protocol. Two-dimensional targeted M-mode echocardiography with Doppler color flow mapping was performed for every patient. Left ventricular dimension was measured according to the American Society of Echocardiography guidelines [22] . Measurements of LV dimension and function were determined on an average of $3 beats. Diastolic mitral flow was assessed by pulsed-wave Doppler echocardiography from the apical four-chamber view. E-wave deceleration time was measured as the interval between the early peak diastolic velocity and the point at which the steepest deceleration slope was extrapolated to the zero line.
Statistical Methods
The measured data were expressed as mean 6 SD or median (interquartile range, IQR) and categorical data were expressed as percentage. Antibody titer was reported as geometric mean. Positive rate of autoantibody was described as the frequency of autoantibody. For two-group comparison, we used the Student's t test or Mann-Whitney U test for continuous variables and the chisquare test or Fisher's exact test for categorical variables. For three-group comparison, Kruskal-Wallis test was used. Correlation between the levels of serum anti-b 1 -AABs or anti-M 2 R-AABs and the echocardiographic and clinical indices were assessed by Spearman's correlation. Risk factor analysis was performed by univariate and multivariate logistic analysis. All tests were 2-tailed, and statistically significant difference was considered at P , 0.05. Statistical analysis was performed using SPSS Base 16.0 statistical software package (SPSS, Inc., Chicago, Illinois).
